National Cancer Institute
ALPHARETTA, GEORGIA (NorthFulton.com) - It's estimated that more than 6,000 men in Georgia, nearly 100 in Forsyth County, will be diagnosed with prostate cancer this year, according to the National Cancer Institute (NCI). It remains the most frequently diagnosed cancer in men, aside from skin cancer. To help raise awareness of the disease, Northside Hospital's Cancer Institute, in collaboration with Georgia Highland Medical Services, is offering a free prostate cancer screening in Forsyth County in March.
Healthcare professionals will screen adult men for symptoms of prostate cancer and offer free protein specific antigen (PSA) blood tests and digital rectal exams at no charge. Uninsured men, age 40-75, who have never been diagnosed with prostate cancer and haven't had a prostate exam within the past year, are eligible to participate.
A limited number of appointments are available for men with insurance.
A nurse navigator is available to help arrange follow-up care, if indicated.
As the state's leader in the fight against prostate cancer, diagnosing and treating more cases of the disease than any other community hospital in Georgia, Northside agrees with guidelines set by the American Urological Association – that the PSA test can provide important information in the diagnosis, pre-treatment staging or risk assessment and monitoring of prostate cancer patients. However, in 2011, the U.S. Preventative Services Task Force (USPSTF), the same group that earlier released controversial recommendations for mammograms, released recommendations discouraging the use of PSA-based screening for prostate cancer, asserting that there is "moderate or high certainty that the service has no net benefit or that the harms outweigh the benefits."
Men are encouraged to talk with their healthcare provider to determine if screening for prostate cancer is appropriate for them.
An NCI Community Cancer Centers Program (NCCCP), Northside leads the way in groundbreaking procedures for better outcomes and less invasive treatments for prostate cancer, offering a wide range of options – from the minimally invasive to the latest advances in surgery.
Men should discuss the benefits and limitations of screening, beginning at age 50 if they are at average risk for the disease, and, beginning at age 45 if they are at high risk. Men at high risk include African-American men and men with a first-degree relative (father, brother, son), diagnosed at an early age (younger than age 65). Men who have several first-degree relatives who had prostate cancer at an early age should discuss the pros and cons of early screening with their physician beginning at age 40.
Copyright 2016 NorthFulton.com
Updated 1676 days ago Article ID# 1469390
National Cancer Institute